Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income (2017 - 2022)
Kiniksa Pharmaceuticals International (KNSA) posted Interest & Investment Income of $322,000 for Q3 2022, compared with $5,000 a year earlier and up 212.6% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income (2017 - 2022) Analysis & Trends
For the trailing twelve months through Sep 30, 2022, Interest & Investment Income at Kiniksa Pharmaceuticals International was $536,000, up 972.0% year-over-year; for FY2021, it came in at $97,000, down 91.4% from FY2020.
- Annual Interest & Investment Income shows a four-year compound annual growth rate of -34.6% (FY2017 to FY2021).
- In prior years, Kiniksa Pharmaceuticals International's Interest & Investment Income was $1.13 million in FY2020 (-81.3%), $6.05 million in FY2019 (+28.2%), $4.72 million in FY2018 (+792.1%) and $529,000 in FY2017.
- The Q3 2022 figure stands as the highest quarterly Interest & Investment Income since Q1 2020.
- On a year-over-year basis, Interest & Investment Income increased in two of the last six quarters, with growth averaging 8.4%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2018, with growth of 859.8%; the weakest was Q1 2021, with a decline of 98.9%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $103,000 (Q2 2022), $34,000 (Q1 2022) and $77,000 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 77,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 30,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 266,000.00 |
| Mar 31, 2020 | 789,000.00 |
| Dec 31, 2019 | 1.13 Mn |
| Sep 30, 2019 | 1.39 Mn |
| Jun 30, 2019 | 1.72 Mn |
| Mar 31, 2019 | 1.81 Mn |
| Dec 31, 2018 | 1.73 Mn |
| Sep 30, 2018 | 1.62 Mn |
| Jun 30, 2018 | 1.07 Mn |
| Mar 31, 2018 | 305,000.00 |
| Dec 31, 2017 | 133,000.00 |
API Access
Kiniksa Pharmaceuticals International Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();